Uncategorized
« Previous EntriesMr Rick Brough named as one of the top 250 doctors in Private Practice in the United Kingdom.
Wednesday, February 13th, 2013Tatler Magazine recently listed the top 250 Consultants in Private Practice. We at Manchester Urology are very pleased to see that Mr Rick Brough was listed as he is one of the Manchester Urology Consultants. Although he covers all aspects of urology he has developed his reputation by being one of the leaders in his field in laparoscopic prostate and… read more
Does aspirin improve survival in prostate cancer?
Tuesday, November 13th, 2012A new study has found that aspirin use is associated with a reduced risk of death from prostate cancer. This adds to
existing evidence supporting its benefits in colorectal cancer. The study looked at patients who had undergone either
radiotherapy or surgery for prostate cancer and found that anticoagulants were associated with a… read more
Manchester Urology Consultant is the first in the UK to use a full 3D projection during an operation.
Tuesday, April 17th, 2012Dan Burke, who led the surgery, said he hoped the technology would become available to many more patients.
“We are already excited at the potential this technology has for performing keyhole surgery.
The technology offers a more precise and quicker surgical procedure, as it provides more flexibility than the human wrist.
to read… read more
For the First time In Britain a Manchester Urology Consultant Performs a Radical Prostatectomy For Prostate Cancer Using a Hand Held Robot.
Friday, March 23rd, 2012Today Neil Oakley, one of the Manchester Urology Consultants, performed the first radical prostatectomy using a hand-held robot in Britain.
The robotic device allows surgeons to combine the touch and feel of traditional surgery with the greater accuracy and dexterity of articulating instruments.
Neil Oakley said “Our team is very excited about this… read more
Urethroplasty verses repeat urethrotomy
Thursday, November 3rd, 2011I am attending the Annual Masterclass on Genito-Urinary Reconstructive Surgery in London and one consensus from the meeting is that following one urethrotomy for urethral stricture disease, patients should be referred for consideration and discussion about formal reconstruction of the urethra. It is well known that after 1 urethrotomy there is a 50% recurrence rate… read more
Radiation therapy following prostatectomy in high risk disease
Tuesday, September 20th, 2011Approximately 15-25% of patients having treatment for prostate cancer with either surgery or radiotherapy (external beam or brachytherapy) will experience a biochemical (PSA) recurrence. One of the advantages of prostatectomy is the ability to give external beam radiotherapy as an additional treatment for those with more advanced disease or positive surgical margins. There has been… read more
Arbiraterone and advanced prostate cancer
Tuesday, September 20th, 2011The results of a phase 3 trial using arbiraterone have been published in the new england journal of medicine. This study has shown that patients with castrate resistant (hormone resistant) prostate cancer responded well to the combination of arbiraterone and prednisolone (a steroid). Those patients on the drug had an improved survival when compared to… read more
Male incontinence: AdVance Male Sling
Sunday, July 24th, 2011Traditionally for men experiencing stress urinary incontinence the artificial urinary sphincter (AUS) has been considered the treatment of choice for all levels of incontinence. The AUS is an excellent treatment but some men consider this to be too much of an undertaking especially if they have mild or moderate incontinence. For men with severe incontinence the… read more
Kidney sparing surgery for cancer is underused
Thursday, November 18th, 2010There is recent evidence that suggests that partial nephrectomy for renal (kidney) cancer may be associated with improved survival compared with removal of the entire kidney. This study shows that because of the difficulty in learning partial nephrectomy (removal of the cancer and leaving the rest of the kidney intact) as a keyhole procedure, patients… read more
PCA3 test may predict prostate cancer occurring in the future
Monday, November 15th, 2010A recent study has added more weight to the usefulness of the urine test PCA3 in the diagnosis of prostate cancer. It has also shown that the test may be predictive of a positive biopsy in the future.
These new results arise from the large REDUCE trial looking at the effect of the drug dutasteride on… read more